Janus Henderson Group PLC Verona Pharma PLC Put Options Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VRNA
# of Institutions
284Shares Held
71.4MCall Options Held
922KPut Options Held
1.97M-
Perceptive Advisors LLC New York, NY6.56MShares$457 Million17.44% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$273 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$241 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$202 Million3.9% of portfolio
-
Rtw Investments, LP New York, NY2.85MShares$199 Million2.96% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.25B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...